Detalles de la búsqueda
1.
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(1): 88-99, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30509771
2.
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Lancet
; 387(10021): 849-56, 2016 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-26686957
3.
Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Lancet
; 387(10021): 857-65, 2016 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-26686960
4.
Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43.
Breast Cancer Res Treat
; 142(2): 415-21, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24202240
5.
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2.
J Clin Oncol
; 35(35): 3942-3948, 2017 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29072977
6.
Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31.
J Clin Oncol
; 23(31): 7811-9, 2005 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16258083
7.
Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin E(1) analog misoprostol (RTOG 96-07).
Int J Radiat Oncol Biol Phys
; 54(5): 1455-9, 2002 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12459369
8.
Gemcitabine and docetaxel for hepatocellular carcinoma: a phase II North Central Cancer Treatment Group clinical trial.
Am J Clin Oncol
; 35(5): 418-23, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21555932
9.
Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08.
J Clin Oncol
; 29(1): 11-6, 2011 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20940184
10.
Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer.
J Clin Oncol
; 28(22): 3611-6, 2010 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20606094
11.
Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer.
J Clin Oncol
; 27(20): 3385-90, 2009 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19414665
12.
Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin: a prospective analysis.
Cancer
; 110(9): 1945-50, 2007 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17853393
13.
Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.
J Clin Oncol
; 25(16): 2205-11, 2007 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17470850
14.
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.
J Clin Oncol
; 25(16): 2198-204, 2007 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17470851
15.
Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.
J Clin Oncol
; 24(13): 2059-64, 2006 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16648506
Resultados
1 -
15
de 15
1
Próxima >
>>